-
1
المؤلفون: Frank Trudo, Gary T. Ferguson, Tor Skärby, Kristina Sandin, Mike Greenwood, Carin Jorup, Donald P. Tashkin, Kristine Pemberton
المصدر: Respiratory medicine. 132
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Budesonide, Adult, Male, medicine.medical_specialty, Exacerbation, Vital Capacity, Severity of Illness Index, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Double-Blind Method, Internal medicine, Forced Expiratory Volume, Formoterol Fumarate, Administration, Inhalation, medicine, Budesonide, Formoterol Fumarate Drug Combination, Humans, 030212 general & internal medicine, Metered Dose Inhalers, Glucocorticoids, Aged, Proportional Hazards Models, Aged, 80 and over, COPD, business.industry, Inhaler, Dry Powder Inhalers, respiratory system, Middle Aged, medicine.disease, Metered-dose inhaler, Dry-powder inhaler, respiratory tract diseases, Bronchodilator Agents, Treatment Outcome, 030228 respiratory system, Budesonide/formoterol, Disease Progression, Female, Formoterol, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039694d1fb5f9f35ac44e5c0dc80fbe7Test
https://pubmed.ncbi.nlm.nih.gov/29229103Test -
2
المؤلفون: Stefan Ivanov, Peter J. Barnes, Eric D. Bateman, Nanshan Zhong, J. Mark FitzGerald, Gun Almqvist, Helen K. Reddel, Christina Keen, Kristine Pemberton, Paul M. O'Byrne, Carin Jorup
المساهمون: Department of Medicine, Faculty of Health Sciences
المصدر: O'Byrne, P, Fitzgerald, J M, Zhong, N S, Bateman, E D, Barnes, P J, Keen, C, Almqvist, G, Pemberton, K, Jorup, C, Ivanov, S & Reddel, H K 2017, ' The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials. ', Trials, vol. 18, no. 1, pp. 12-25 . https://doi.org/10.1186/s13063-016-1731-4Test
Trialsمصطلحات موضوعية: Budesonide, As-needed, PERSISTENT ASTHMA, Prn, Medicine (miscellaneous), Research & Experimental Medicine, INHALED CORTICOSTEROIDS, Study Protocol, 0302 clinical medicine, Clinical Protocols, RELIEVER THERAPY, Formoterol Fumarate, Pharmacology (medical), 030212 general & internal medicine, Rescue inhaler, Randomized Controlled Trials as Topic, FORMOTEROL, SYGMA, Medicine, Research & Experimental, Life Sciences & Biomedicine, medicine.drug, medicine.medical_specialty, Terbutaline, Mild asthma, Placebo, 1102 Cardiovascular Medicine And Haematology, Exacerbations, INTERMITTENT, 03 medical and health sciences, Double-Blind Method, General & Internal Medicine, Internal medicine, Asthma control, medicine, Humans, COMBINATION, Budesonide/formoterol, Asthma, Science & Technology, business.industry, 1103 Clinical Sciences, medicine.disease, PREVENTION, respiratory tract diseases, Patient recruitment, Cardiovascular System & Hematology, Clinical Trials, Phase III as Topic, 030228 respiratory system, CLINICAL-PRACTICE, Sample Size, Physical therapy, Formoterol, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3466afaa55bfc3a4cb3b796c823b40Test
https://hdl.handle.net/11427/24047Test -
3
المؤلفون: Stuart McIntosh, Joel B. Nelson, Kurt Miller, Celestia S. Higano, F. E. Nathan, Kristine Pemberton, Thomas Morris, Martin E. Gleave, Karim Fizazi, Judd W. Moul
المصدر: Prostate cancer and prostatic diseases. 16(2)
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Pyrrolidines, Urology, Placebo-controlled study, Administration, Oral, Antineoplastic Agents, Kaplan-Meier Estimate, Adenocarcinoma, Placebo, Drug Administration Schedule, law.invention, chemistry.chemical_compound, Randomized controlled trial, Double-Blind Method, law, medicine, Edema, Humans, Aged, Proportional Hazards Models, Aged, 80 and over, Zibotentan, business.industry, Standard treatment, Hazard ratio, Middle Aged, Interim analysis, Clinical trial, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Oncology, chemistry, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1661aad8567173dd3c1e1cc27a7098cfTest
https://pubmed.ncbi.nlm.nih.gov/23381694Test -
4
المؤلفون: Antonella Savarese, E Mari, Pauline Wimberger, Francesco Cognetti, Giovanni Scambia, Klaus Baumann, Nicoletta Colombo, Kristine Pemberton, F. E. Nathan, P. Harter, Anna Bagnato, Stuart McIntosh, Roberto Sorio, Jalid Sehouli
المساهمون: Cognetti, F, Bagnato, A, Colombo, N, Savarese, A, Scambia, G, Sehouli, J, Wimberger, P, Sorio, R, Harter, P, Mari, E, Mcintosh, S, Nathan, F, Pemberton, K, Baumann, K
المصدر: Gynecologic oncology. 130(1)
مصطلحات موضوعية: Oncology, Pyrrolidines, medicine.medical_treatment, Medizin, Carcinoma, Ovarian Epithelial, ZD4054, Pyrrolidine, Carboplatin, Placebos, chemistry.chemical_compound, Antineoplastic Combined Chemotherapy Protocols, Neoplasms, Glandular and Epithelial, carboplatin/paclitaxel, Cancer, zibotentan, Ovarian Neoplasms, Zibotentan, Obstetrics and Gynecology, Middle Aged, Paclitaxel, Tolerability, Ovarian, Female, Human, Adult, medicine.medical_specialty, Placebo, Disease-Free Survival, Drug Administration Schedule, Young Adult, Double-Blind Method, Internal medicine, medicine, Humans, Aged, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Ovarian Neoplasm, medicine.disease, Surgery, Settore MED/40 - GINECOLOGIA E OSTETRICIA, chemistry, Advanced, Ovarian cancer, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dd647d4e8e411e2e422e120a87867b1Test
https://pubmed.ncbi.nlm.nih.gov/23234805Test -
5
المؤلفون: Christos Chouaid, Thomas Morris, Kristine Pemberton, F. E. Nathan
المساهمون: Epidémiologie des maladies infectieuses et modélisation (ESIM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), AstraZeneca
المصدر: Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology, Springer Verlag, 2011, 67 (5), pp.1203-8. ⟨10.1007/s00280-010-1538-z⟩
Cancer Chemotherapy and Pharmacology, Springer Verlag, 2010, 67 (5), pp.1203-1208. ⟨10.1007/s00280-010-1538-z⟩
Cancer Chemotherapy and Pharmacology, 2011, 67 (5), pp.1203-8. ⟨10.1007/s00280-010-1538-z⟩مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Guanine, Lung Neoplasms, Pyrrolidines, Randomization, Pemetrexed, Toxicology, NSCLC, Endothelin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Glutamates, Zibotentan, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Neoplasm Metastasis, Lung cancer, Survival rate, ComputingMilieux_MISCELLANEOUS, Cancer, Pharmacology, business.industry, medicine.disease, 3. Good health, Surgery, Survival Rate, Clinical trial, Tolerability, chemistry, 030220 oncology & carcinogenesis, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c33d41804d7d57e2e805c34ff8a4419Test
https://hal.sorbonne-universite.fr/hal-00596809Test